UniProtKB/Swiss-Prot Q9NNW7: Variant p.Ile370Thr

Thioredoxin reductase 2, mitochondrial
Gene: TXNRD2
Feedback?

Variant information Variant position:

370 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Isoleucine (I) to Threonine (T) at position 370 (I370T, p.Ile370Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (I) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1139793 [ dbSNP | Ensembl ]

Sequence information Variant position:

370 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

524 The length of the canonical sequence.
Location on the sequence:

SVPHIYAIGDVVEGRPELTP I AIMAGRLLVQRLFGGSSDLM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SVPHIYAIGDVVEGRPELTPIAIMAGRLLVQRLFGGSSDLM

Mouse                         SVPHIYAIGDVAEGRPELTPTAIKAGKLLAQRLFGKSSTLM

Rat                           SVPHIYAIGDVAEGRPELTPTAIKAGKLLAQRLFGKSSTLM

Bovine                        SVPHIYAIGDVAEGRPELTPTAIMAGRLLAQRLSGRTSDLM

Caenorhabditis elegans        SCNGVYAVGDIVQDRQELTPLAIQSGKLLADRLFSNSKQIV

Drosophila                    SVPHIFAVGDIIYGRPELTPVAILSGRLLARRLFAGSTQLM

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	37 – 524	Thioredoxin reductase 2, mitochondrial

Literature citations
Submission
Toji S.; Yano M.; Tamai K.;
Cited for: NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 2); VARIANT THR-370; Novel selenoproteins identified in silico and in vivo by using a conserved RNA structural motif.
Lescure A.; Gautheret D.; Carbon P.; Krol A.;
J. Biol. Chem. 274:38147-38154(1999)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4); ALTERNATIVE SPLICING; TISSUE SPECIFICITY; VARIANT THR-370; Submission
Kim J.-R.; Lee Y.H.; Lee S.-R.; Kim B.H.; Rhee S.G.; Kim J.H.;
Cited for: NUCLEOTIDE SEQUENCE (ISOFORM 1); VARIANTS SER-66 AND THR-370; Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD).
Prasad R.; Chan L.F.; Hughes C.R.; Kaski J.P.; Kowalczyk J.C.; Savage M.O.; Peters C.J.; Nathwani N.; Clark A.J.; Storr H.L.; Metherell L.A.;
J. Clin. Endocrinol. Metab. 99:E1556-E1563(2014)
Cited for: FUNCTION; TISSUE SPECIFICITY; INVOLVEMENT IN GCCD5; VARIANT GCCD5 447-TYR--GLY-524 DEL; CHARACTERIZATION OF VARIANT GCCD5 447-TYR--GLY-524 DEL; VARIANTS SER-66; ARG-299 AND THR-370;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.